SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?


To: Jim Bishop who wrote (73130)12/4/2000 4:31:14 AM
From: SSP  Respond to of 150070
 
GILAT SATELLITE NETWORKS LTD - KSAT And Gilat Target China; Part One of
Doppler Report

New York, New York, Dec. 04, 2000 (Market News Publishing via COMTEX) --
High-speed Internet access became available to consumers in 1996 and the
technology has proven to be extremely popular - at least among those fortunate
enough to live in an area where broadband service is available.

In the United States, for example, once you get outside of the major
metropolitan areas, there are not many cable companies that have upgraded their
infrastructure and are offering broadband access. Similarly, when you get more
than about three miles (as measured by the length of the cable) away from a
telephone switching station, the benefits of DSL are lost.

In America (a country that thinks of itself as a telecommunications leader),
that translates into more than 50 million people who live in areas where
broadband Internet service is unavailable. Analysts believe that about half of
these people are on-line, but have to make do with slow, land-based access to
the Internet through dial-up modems.

The problem in the People's Republic of China is even more acute. China's
Internet system is both extremely slow and very limited. Each day, millions of
users attempt to log onto an already-overcrowded telecommunications network.

At the same time as demand for Internet access in China is growing
exponentially, the government is struggling to complete installation of Internet
infrastructure in China's major cities. The problem in rural areas of China is
far worse, with much of the country still waiting to be wired and connected to
old-style, fixed-line telephone services.

On October 29th, Owen Brown of Dow Jones Newswire's Beijing office reported
that, according to the official Xinhua News Agency, the Chinese government had
decided to spend millions of dollars to improve its Internet services using
satellite communication technology from Israel's Gilat Satellite Networks and
that Shanghai has also decided to set up a Very Small Aperture Terminal, or
VSAT, application and research center with Gilat Satellite Networks.

What's significant here is that a little-known, CDNX-listed company called KSAT
Satellite Technology, Inc. (37% owned by GILTF) is the business that will be
manufacturing, selling and delivering GILTF's satellite communication technology
that's going to be instrumental in improving China's Internet services. By
providing two-way, high-speed Internet access via satellites, KSAT can help
China solve its acute shortage of high-speed telecommunications equipment /
infrastructure, and make broadband service available to millions of businesses
and consumers.


TOLL FREE: 1-877-222-8701 Ora Capital
E-MAIL: ora-bay@home.com
WEBSITE: ksat.net



To: Jim Bishop who wrote (73130)12/4/2000 10:58:48 AM
From: Jim Bishop  Read Replies (1) | Respond to of 150070
 
UTHR getting hammered on this...

Monday, December 04, 2000

UTHR projections disappoint
--10:13 am - By Michael Baron
United Therapeutics (UTHR: news, msgs) is plunging $28.25, or 59.3 percent, to $19.38, after the Silver Springs, Md., biotechnology firm said it expects revenue of $10 million to $20 million in fiscal 2001 from UT-15, or Uniprost, its subcutaneous treatment for pulmonary arterial hypertension. Deutsche Banc Alex Brown cut its rating on UTHR to "market perform," saying this projection is significantly below its expectations for revenue of $80 million. United Therapeutics said the FDA has indicated its cardiovascular and renal drugs advisory committee will review the company's new drug application for UT-15 on February 9. The company said it expects revenue of $75 million to $100 million from Uniprost in 2002. Deutsche Banc was looking for revenue of $170 million in the same period. In addition, United Therapeutics co-founder James Crow will retire as president and chief operating officer when the company obtains FDA approval for UT-15. Crow will be replaced by Roger Jeffs, vice president for clinical, scientific & medical affairs. Other negative developments, according to Deutsche Banc, include the slow enrollment in UTHR's open-label study of UT-15, and the company's decision to seek approvals on a country by country basis in Europe. The firm had been anticipating a Europe-wide filing in the fourth quarter.